JiangXi Tianxin Pharmaceutical Co., Ltd. (SHA:603235)

Market Cap	10.53B -8.6%
Revenue (ttm)	2.37B +1.4%
Net Income	520.02M -28.0%
EPS	1.19 -27.9%
Shares Out	435.17M
PE Ratio	20.34
Forward PE	n/a
Dividend	0.55 (2.27%)
Ex-Dividend Date	Jun 17, 2025

Volume	509,700
Open	24.10
Previous Close	24.18
Day's Range	24.10 - 24.56
52-Week Range	24.10 - 30.02
Beta	0.33
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About SHA:603235

JiangXi Tianxin Pharmaceutical Co., Ltd. produces and sells vitamins in China. The company offers products of vitamin B6, vitamin B1, Vitamin D3, pyridoxine hydrochloride CD grade, thiamine nitrate DC grade, folic acid, biotin, ascorbyl palmitate, vitamin E 500, α-acetyl-γ-butyrolactone, and vitamin D3 for use as bulk pharmaceutical chemicals, API, food additives, and feed additives, as well as in other fields. JiangXi Tianxin Pharmaceutical Co., Ltd. was founded in 2004 and is based in Leping, China.

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 2004
• Employees: 2,893
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603235

Financial Performance

In 2025, SHA:603235's revenue was 2.35 billion, an increase of 6.18% compared to the previous year's 2.21 billion. Earnings were 591.58 million, a decrease of -9.16%.